High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

Yazar: Gambella, Manuela, Rocci, Alberto, Passera, Roberto, Gay, Francesca, Omedè, Paola, Crippa, Claudia, Corradini, Paolo, Romano, Alessandra, Rossi, Davide, Ladetto, Marco, Boccadoro, Mario, Palumbo, Antonio
Baskı/Yayın Bilgisi 2014

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status

Yazar: Foglietta, Myriam, Castella, Barbara, Mariani, Sara, Coscia, Marta, Godio, Laura, Ferracini, Riccardo, Ruggeri, Marina, Muccio, Vittorio, Omedé, Paola, Palumbo, Antonio, Boccadoro, Mario, Massaia, Massimo
Baskı/Yayın Bilgisi 2014

Droplet Digital PCR Assay for MYD88(L265P): Clinical Applications in Waldenström Macroglobulinemia

Yazar: Lo Schirico, Mariella, Ferrante, Martina, Dogliotti, Irene, Zamò, Alberto, Ferrero, Bruno, Bertuzzo, Davide, Benevolo, Giulia, Omedè, Paola, Cavallo, Federica, Ladetto, Marco, Boccadoro, Mario, Drandi, Daniela, Ferrero, Simone
Yayımlandı Hemasphere (2020)

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma

Yazar: Castella, Barbara, Foglietta, Myriam, Sciancalepore, Patrizia, Rigoni, Micol, Coscia, Marta, Griggio, Valentina, Vitale, Candida, Ferracini, Riccardo, Saraci, Elona, Omedé, Paola, Riganti, Chiara, Palumbo, Antonio, Boccadoro, Mario, Massaia, Massimo
Yayımlandı Oncoimmunology (2015)

Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System

Yazar: Almici, Camillo, Neva, Arabella, Skert, Cristina, Bruno, Benedetto, Verardi, Rosanna, Di Palma, Andrea, Bianchetti, Andrea, Braga, Simona, Piovani, Giovanna, Cancelli, Valeria, Omedè, Paola, Baeten, Kurt, Rotta, Gianluca, Russo, Domenico, Marini, Mirella
Yayımlandı Sci Rep (2019)

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

Yazar: Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola
Baskı/Yayın Bilgisi 2014

Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network

Yazar: op Bruinink, Davine Hofste, Oliva, Stefania, Rihova, Lucie, Schmitz, Alexander, Gilestro, Milena, te Marvelde, Jeroen, Kralova, Romana, Høholt, Helle, Broijl, Annemiek, Johnsen, Hans Erik, Hajek, Roman, Boccadoro, Mario, Sonneveld, Pieter, Omedè, Paola, van der Velden, Vincent H.J.
Yayımlandı Haematologica (2020)

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes

Yazar: Zaccaria, Gian Maria, Ferrero, Simone, Rosati, Samanta, Ghislieri, Marco, Genuardi, Elisa, Evangelista, Andrea, Sandrone, Rebecca, Castagneri, Cristina, Barbero, Daniela, Lo Schirico, Mariella, Arcaini, Luca, Molinari, Anna Lia, Ballerini, Filippo, Ferreri, Andres, Omedè, Paola, Zamò, Alberto, Balestra, Gabriella, Boccadoro, Mario, Cortelazzo, Sergio, Ladetto, Marco
Yayımlandı JCO Clin Cancer Inform (2019)

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies

Yazar: Mina, Roberto, Bonello, Francesca, Petrucci, Maria Teresa, Liberati, Anna Marina, Conticello, Concetta, Ballanti, Stelvio, Musto, Pellegrino, Olivieri, Attilio, Benevolo, Giulia, Capra, Andrea, Gilestro, Milena, Galieni, Piero, Cavo, Michele, Siniscalchi, Agostina, Palumbo, Antonio, Montefusco, Vittorio, Gaidano, Gianluca, Omedé, Paola, Boccadoro, Mario, Bringhen, Sara
Yayımlandı Haematologica (2020)

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial

Yazar: Bomben, Riccardo, Ferrero, Simone, D’Agaro, Tiziana, Dal Bo, Michele, Re, Alessandro, Evangelista, Andrea, Carella, Angelo Michele, Zamò, Alberto, Vitolo, Umberto, Omedè, Paola, Rusconi, Chiara, Arcaini, Luca, Rigacci, Luigi, Luminari, Stefano, Piccin, Andrea, Liu, Delong, Wiestner, Adrian, Gaidano, Gianluca, Cortelazzo, Sergio, Ladetto, Marco, Gattei, Valter
Yayımlandı Haematologica (2018)

Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia

Yazar: Drandi, Daniela, Genuardi, Elisa, Dogliotti, Irene, Ferrante, Martina, Jiménez, Cristina, Guerrini, Francesca, Schirico, Mariella Lo, Mantoan, Barbara, Muccio, Vittorio, Lia, Giuseppe, Zaccaria, Gian Maria, Omedè, Paola, Passera, Roberto, Orsucci, Lorella, Benevolo, Giulia, Cavallo, Federica, Galimberti, Sara, Sanz, Ramón García, Boccadoro, Mario, Ladetto, Marco, Ferrero, Simone
Yayımlandı Haematologica (2018)

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma

Yazar: Giaccone, Luisa, Storer, Barry, Patriarca, Francesca, Rotta, Marcello, Sorasio, Roberto, Allione, Bernardino, Carnevale-Schianca, Fabrizio, Festuccia, Moreno, Brunello, Lucia, Omedè, Paola, Bringhen, Sara, Aglietta, Massimo, Levis, Alessandro, Mordini, Nicola, Gallamini, Andrea, Fanin, Renato, Massaia, Massimo, Palumbo, Antonio, Ciccone, Giovannino, Storb, Rainer, Gooley, Ted A., Boccadoro, Mario, Bruno, Benedetto
Baskı/Yayın Bilgisi 2011

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis

Yazar: Oliva, Stefania, Gambella, Manuela, Gilestro, Milena, Muccio, Vittorio Emanuele, Gay, Francesca, Drandi, Daniela, Ferrero, Simone, Passera, Roberto, Pautasso, Chiara, Bernardini, Annalisa, Genuardi, Mariella, Patriarca, Francesca, Saraci, Elona, Petrucci, Maria Teresa, Pescosta, Norbert, Liberati, Anna Marina, Caravita, Tommaso, Conticello, Concetta, Rocci, Alberto, Musto, Pellegrino, Boccadoro, Mario, Palumbo, Antonio, Omedè, Paola
Yayımlandı Oncotarget (2016)

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis

Yazar: Bonello, Francesca, Pulini, Stefano, Ballanti, Stelvio, Gentile, Massimo, Spada, Stefano, Annibali, Ombretta, Omedé, Paola, Ronconi, Sonia, Cangialosi, Clotilde, Podda, Luigi, Palmas, Angelo, Malfitano, Alessandra, Rivoli, Giulia, Belotti, Angelo, Ciambelli, Fabrizio, Vincelli, Iolanda Donatella, Cafro, Anna Maria, Innao, Vanessa, Palumbo, Antonio, Sonneveld, Pieter, Spencer, Andrew, Hájek, Roman, Boccadoro, Mario, Gay, Francesca
Yayımlandı Cancers (Basel) (2019)

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

Yazar: Mina, Roberto, Joseph, Nisha S., Gay, Francesca, Kastritis, Efstathios, Petrucci, Maria Teresa, Kaufman, Jonathan L., Montefusco, Vittorio, Gavriatopoulou, Maria, Patriarca, Francesca, Omedé, Paola, Boise, Lawrence H., Roussou, Maria, Giuliani, Nicola, Oliva, Stefania, Offidani, Massimo, Belotti, Angelo, Jaye, David L., De Paoli, Lorenzo, Terpos, Evangelos, Lonial, Sagar, Boccadoro, Mario, Nooka, Ajay K., Dimopoulos, Meletios A.
Yayımlandı Blood Cancer J (2020)

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

Yazar: Griggio, Valentina, Vitale, Candida, Todaro, Maria, Riganti, Chiara, Kopecka, Joanna, Salvetti, Chiara, Bomben, Riccardo, Bo, Michele Dal, Magliulo, Daniela, Rossi, Davide, Pozzato, Gabriele, Bonello, Lisa, Marchetti, Monia, Omedè, Paola, Kodipad, Ahad Ahmed, Laurenti, Luca, Del Poeta, Giovanni, Mauro, Francesca Romana, Bernardi, Rosa, Zenz, Thorsten, Gattei, Valter, Gaidano, Gianluca, Foà, Robin, Massaia, Massimo, Boccadoro, Mario, Coscia, Marta
Yayımlandı Haematologica (2020)

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

Yazar: Oliva, Stefania, Bruinink, Davine Hofste op, Rihova, Lucie, D’Agostino, Mattia, Pantani, Lucia, Capra, Andrea, van der Holt, Bronno, Troia, Rossella, Petrucci, Maria Teresa, Villanova, Tania, Vsianska, Pavla, Jugooa, Romana, Brandt-Hagens, Claudia, Gilestro, Milena, Offidani, Massimo, Ribolla, Rossella, Galli, Monica, Hajek, Roman, Gay, Francesca, Cavo, Michele, Omedé, Paola, van der Velden, Vincent H. J., Boccadoro, Mario, Sonneveld, Pieter
Yayımlandı Blood Cancer J (2021)

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

Yazar: Saltarella, Ilaria, Morabito, Fortunato, Giuliani, Nicola, Terragna, Carolina, Omedè, Paola, Palumbo, Antonio, Bringhen, Sara, De Paoli, Lorenzo, Martino, Enrica, Larocca, Alessandra, Offidani, Massimo, Patriarca, Francesca, Nozzoli, Chiara, Guglielmelli, Tommasina, Benevolo, Giulia, Callea, Vincenzo, Baldini, Luca, Grasso, Mariella, Leonardi, Giovanna, Rizzo, Manuela, Falcone, Antonietta Pia, Gottardi, Daniela, Montefusco, Vittorio, Musto, Pellegrino, Petrucci, Maria Teresa, Dammacco, Franco, Boccadoro, Mario, Vacca, Angelo, Ria, Roberto
Yayımlandı J Hematol Oncol (2019)